Resultados de procura - Scherrer, Didier
- Mostrando 1 - 8 Resultados de 8
-
1
The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated Macrophages por Chebli, Karim, Papon, Laura, Paul, Conception, Garcel, Aude, Campos, Noëlie, Scherrer, Didier, J. Ehrlich, Hartmut, Hahne, Michael, Tazi, Jamal
Publicado 2017Text -
2
RNA sequencing analysis of activated macrophages treated with the anti-HIV ABX464 in intestinal inflammation por Manchon, Laurent, Chebli, Karim, Papon, Laura, Paul, Conception, Garcel, Aude, Campos, Noëlie, Scherrer, Didier, Ehrlich, Hartmut, Hahne, Michael, Tazi, Jamal
Publicado 2017Text -
3
Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects por Scherrer, Didier, Rouzier, Regine, Cardona, Marine, Barrett, P. Noel, Steens, Jean-Marc, Gineste, Paul, Murphy, Robert L., Tazi, Jamal, Ehrlich, Hartmut J.
Publicado 2016Text -
4
Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study por Steens, Jean-Marc, Scherrer, Didier, Gineste, Paul, Barrett, P. Noel, Khuanchai, Supparatpino, Winai, Ratanasuwan, Ruxrungtham, Kiat, Tazi, Jamal, Murphy, Robert, Ehrlich, Hartmut
Publicado 2017Text -
5
Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phas... por Rutsaert, Sofie, Steens, Jean-Marc, Gineste, Paul, Cole, Basiel, Kint, Sam, Barrett, P Noel, Tazi, Jamal, Scherrer, Didier, Ehrlich, Hartmut J, Vandekerckhove, Linos
Publicado 2019Text -
6
Safety and efficacy of the miR-124 upregulator ABX464 (obefazimod, 50 and 100 mg per day) in patients with active rheumatoid arthritis and inadequate response to methotrexate and/o... por Daien, Claire, Krogulec, Marek, Gineste, Paul, Steens, Jean-Marc, Desroys du Roure, Laurence, Biguenet, Sophie, Scherrer, Didier, Santo, Julien, Ehrlich, Hartmut, Durez, Patrick
Publicado 2022Text -
7
Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing por Vautrin, Audrey, Manchon, Laurent, Garcel, Aude, Campos, Noëlie, Lapasset, Laure, Laaref, Abdelhamid Mahdi, Bruno, Roman, Gislard, Marie, Dubois, Emeric, Scherrer, Didier, Ehrlich, J Hartmut, Tazi, Jamal
Publicado 2019Text -
8
Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis por Campos, Noëlie, Myburgh, Renier, Garcel, Aude, Vautrin, Audrey, Lapasset, Laure, Nadal, Erika Schläpfer, Mahuteau-Betzer, Florence, Najman, Romain, Fornarelli, Pauline, Tantale, Katjana, Basyuk, Eugénia, Séveno, Martial, Venables, Julian P, Pau, Bernard, Bertrand, Edouard, Wainberg, Mark A, Speck, Roberto F, Scherrer, Didier, Tazi, Jamal
Publicado 2015Text